Loading...
Market
Cradle Healthcare starts human trials by end of 2024?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Official press release or news announcement from Cradle Healthcare
Story
Laura Deming's Cradle Healthcare Raises $48M for Reversible Cryopreservation, Achieves Frozen Rat Brain Revival
Jun 3, 2024, 04:02 PM
Cradle Healthcare, a startup founded by Thiel fellow Laura Deming, has raised $48 million to advance reversible cryopreservation technology. The company focuses on reanimating frozen body tissue, aiming to make cryonics a viable option for humans. Deming, known for her work in longevity, emphasizes the importance of not just freezing but also reviving tissues with full functionality. In her first interview about the startup, Deming highlighted Cradle Healthcare's achievement of recovered neuronal activity from frozen rat brains, a significant milestone in the field. The team, praised for matching the ambition of their groundbreaking idea, is one of the few capable of making reversible cryopreservation work.
View original story
Similar markets
Yes • 50%
No • 50%
Less than $50M • 33%
$50M to $100M • 33%
More than $100M • 33%
Sequoia Capital • 25%
Andreessen Horowitz • 25%
Greylock Partners • 25%
SoftBank Vision Fund • 25%
Organ transplants • 33%
Long-distance space travel • 33%
Medical research • 33%
Long-term space travel • 33%
Organ transplants • 33%
Medical research • 33%
Yes • 50%
No • 50%
